Cite

HARVARD Citation

    Coleman, R. et al. (2020). Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial. Lancet oncology. 21 (1), pp. 60-72. [Online]. 
  
Back to record